Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Health and Ventilator-associated Pneumonia
NCT00123123Phase 2Completed
- Sponsor
- University at Buffalo
- Start
- Mar 2004
- Primary completion
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of chlorhexidine in ventilator-associated pneumonia (VAP) (3 arms), sponsored by University at Buffalo. Primary endpoint: Colonization of the Oral Cavity by Respiratory Pathogens. Started Mar 2004; status: completed.
02
Drugs
chlorhexidine
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on NCT00123123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00123123.